Historical record - last NADAC effective date: 11/20/2019
Product Information
RANITIDINE 75 MG TABLET is a generic product labeled by Dr. Reddy's Laboratories Inc., priced at $0.0793 per EA under NDC 55111013160. Its NADAC has been published 69 times since Jul 24, 2019.
FDA first approved this application on Mar 28, 2000.
Strength
75 mg/1
Manufacturer
Dr. Reddy's Laboratories Inc.NDC
55111013160
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Effective Date
11/20/2019
Active Ingredients
RANITIDINE HYDROCHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA075294FDA Approved
3/28/2000
On Market Since
3/1/2000
Pharmacological Classes
Price Statistics
The NADAC for RANITIDINE 75 MG TABLET has been published 69 times since Jul 24, 2019, and over the history we have for it it has risen 7.2%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0793 per EA |
|---|---|
| All-time high | $0.0799 (Sep 11, 2019) |
| All-time low | $0.0740 (Jul 24, 2019) |
| Median price | $0.0793 |
| Average price | $0.0789 |
| Largest weekly change | +7.9% (Aug 21, 2019) |
| Weeks tracked | 69 |
| Tracking since | Jul 24, 2019 |
1W
N/A
1M
N/A
3M
N/A
6M
N/A
1Y
N/A
3Y
N/A
5Y
N/A
All
+7.2%
Last surveyed Nov 11, 2020 — this NDC no longer appears in the current weekly NADAC file.
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the Ranitidine market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Dr. Reddy's Laboratories Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Ranitidine market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Histamine-2 Receptor Antagonist class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of RANITIDINE 75 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for RANITIDINE 75 MG TABLET, manufactured by Dr. Reddy's Laboratories Inc., is $0.0793 per EA (NDC 55111013160), effective Nov 11, 2020.
How has the price of RANITIDINE 75 MG TABLET changed over time?
Over the history we have for it, the NADAC for RANITIDINE 75 MG TABLET has risen 7.2%. It has been tracked across 69 weekly CMS publications since Jul 24, 2019.
What are the highest and lowest recorded NADAC prices for RANITIDINE 75 MG TABLET?
Since Jul 24, 2019, the NADAC for RANITIDINE 75 MG TABLET has ranged from a low of $0.0740 (Jul 24, 2019) to a high of $0.0799 (Sep 11, 2019), with a median of $0.0793 per EA.
Are there cheaper alternatives to RANITIDINE 75 MG TABLET?
No other NADAC-published product currently shares the active ingredient and strength of RANITIDINE 75 MG TABLET in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures RANITIDINE 75 MG TABLET?
RANITIDINE 75 MG TABLET (NDC 55111013160) is labeled by Dr. Reddy's Laboratories Inc., and CMS classifies it as a generic product.